Body
Body
Two scientists at work; a smiling young woman cares for a man in a wheelchair.

Keeping the   
momentum going

Background video

Animated canvas: two scientists at work; a smiling young woman cares for a man in a wheelchair.

Body
 

Investing for future generations

 

Dr. Reddy’s Biologics is actively investing in a better, healthier tomorrow through our robust biologics and biosimilars pipelines.       

Whether it’s through innovation or investment, our unwavering goal is to work with our partners to bring about the most positive impact for patients.       

Our most recent opportunity to make a meaningful difference is happening at our new US-based Biologics division.

lab scientist looks into a microscopeinset of a double helixthree generations of womena pair of gloved hands extracts liquid from a dish with an eye droppera doctor talks to a family
Body

Our pipeline of biosimilar assets across therapeutic and biologic areas

 

2024-2027

Rheumatology – Rituximab 
(licensed to Fresenius Kabi); 
Denosumab; 
Abatacept

Oncology – Denosumab

Rare Disease/ALS – COYA 302

2028-2030

Oncology – 4

Rheumatology – 3

Dermatology – 1

2031-2034

Oncology – 4

Dermatology – 1

Hematology – 1

2034+

Oncology – 1

Hematology – 1

Body

The information contained in this chart was current as of its date of publication. While this pipeline chart remains on the company’s website the company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the pipeline chart and investors should not rely upon the information as current or accurate after its date of publication.

Body
 

Get the latest news on     
Dr. Reddy’s Biologics

Take me there

A physician on the go consults her notes